… The leukotrienes are … local montelukast, a cysteinyl leukotriene receptor antagonist, and
the possible involvement of L-arginine/NO/cGMP/K ATP channel pathway and PPARγ receptors …

… Montelukast, a cysteinyl LT receptor antagonist (LTD 4 … Furthermore, we revealed that
montelukast exerts an anti-… Also, montelukast may have anti-inflammatory effects through …

… that ethanol stimulates the LTC 4 generation, cysteinyl LTs, and 15-… of cysteinyl LT receptors,
such as the interaction with the … effect in a local inflammatory pain models in rats (Alizamani …

… Significance: Mont exerted the biochemical and … a selective cysteinyl leukotriene receptor
antagonist, with anti-oxidant, anti-inflammatory, and anti-apoptotic effects in different models of …

… available but montelukast (MTK)—an antagonist of the cysteinyl … are the cysteinyl leukotriene
receptors 1 (CysLTR 1 ) and 2 (… Local antinociception model of pain Pharmacological …

… of montelukast is the block of cysteinyl leukotriene (cys-LT) … that antinociception was elicited
in various inflammatory pain … the montelukast inhibit peripheral PPARγ receptors and exert …

… and inhibition of pain transmission by acting on K ATP channels. The current study provides
… a new local antinociceptive agent that can exert its peripheral antinociceptive effect through …

… )–K + channel pathway on the local antinociception induced by … of opioid receptors, the
NO–cGMP–K + channels pathway, … , inflammation, and pain. There are four G-protein-coupled …

… Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal
model of pain through the L-arginine/nitric oxide/cyclic GMP/K(ATP) channel pathway and …

… , exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic
GMP/KATP channel pathway and PPARγ receptors, International Journal …